MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
16.29
-0.06 (-0.37%)
Aug 18, 2026, 1:12 PM EDT - Market open

MLTX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-263.67-227.32-118.94-36.01-49.97-64.37
Depreciation & Amortization
3.242.621.390.370.160.01
Asset Writedown & Restructuring Costs
-----5.82
Stock-Based Compensation
23.212.97.287.119.6510.86
Other Operating Activities
-0.95-4.08-2.53-8.03-14.160.09
Change in Accounts Receivable
-3.15-2.03-1.79-0.84-0.07-0.18
Change in Accounts Payable
-0.0420.567.161.58-1.311.88
Change in Other Net Operating Assets
16.21.34-9.15-6.96-0.23.68
Operating Cash Flow
-225.18-196.01-116.59-42.78-55.89-42.21
Operating Cash Flow Growth
------
Capital Expenditures
--0.04-0.52-0.28-0.02-0.06
Investment in Securities
58.91203.03-205.08-24.9-32.32-
Investing Cash Flow
58.91202.99-205.6-25.18-32.34-0.06
Long-Term Debt Issued
-73.02----
Total Debt Issued
24.4773.02---18
Short-Term Debt Repaid
-----15-
Total Debt Repaid
-----15-
Net Debt Issued (Repaid)
24.4773.02---1518
Issuance of Common Stock
313.6772.9852.78482.450.050.13
Repurchase of Common Stock
------0.01
Other Financing Activities
---1.47-2.75134.65-
Financing Cash Flow
338.1414651.31479.7119.6951.92
Foreign Exchange Rate Adjustments
-0.651.110.13-0.080.010
Net Cash Flow
171.22154.09-270.74411.6631.479.65
Free Cash Flow
-225.18-196.04-117.11-43.06-55.91-42.27
Free Cash Flow Growth
------
Free Cash Flow Per Share
-3.26-3.04-1.86-0.88-1.90-5.39
Levered Free Cash Flow
-131.86-120.38-92.06-24.14-32.23-
Unlevered Free Cash Flow
-125.55-115.85-92.06-24.14-32.23-
Cash Interest Paid
7.865.06----
Cash Income Tax Paid
0.80.80.150.040-
Change in Working Capital
1319.88-3.78-6.22-1.585.38
SEC Filings: 10-K · 10-Q